Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bally

Showing results (71-80 of 225) with videos related to

Pageof 23
Sort By:
Vaccine|May 4, 2004
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopesMarie-Paule M Schutze-Redelmeier, Spencer Kong, Marcel B Bally, et al.
Drug Delivery and Translational Research|June 19, 2019
Liposomal OTS964, a TOPK inhibitor: a simple method to estimate OTS964 association with liposomes that relies on enhanced OTS964 fluorescence when bound to albuminRoger Gilabert-Oriol, Brent W Sutherland, Malathi Anantha, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing miceM B Bally, D Masin, R Nayar, et al.
Cancer Research|February 1, 1990
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumorsL D Mayer, M B Bally, H Loughrey, et al.
British Journal of Cancer|March 1, 1995
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumoursL D Mayer, D Masin, R Nayar, et al.
Vaccine|June 14, 2003
Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomesWai Ming Li, Wieslawa H Dragowska, Marcel B Bally, et al.
Anticancer Research|July 9, 2011
Development of glioblastoma cell lines expressing red fluorescence for non-invasive live imaging of intracranial tumorsM Verreault, D Strutt, D Masin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2018
Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitorAda W Y Leung, Malathi Anantha, Wieslawa H Dragowska, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumorsH J Lim, D Masin, N L McIntosh, et al.
Nanomedicine (London, England)|November 15, 2011
Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapyDawn N Waterhouse, Donald Yapp, Maite Verreault, et al.
Pageof 23

Showing results (71-80 of 225) with videos related to

Sort By:
Pageof 23
Vaccine|May 4, 2004
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopesMarie-Paule M Schutze-Redelmeier, Spencer Kong, Marcel B Bally, et al.
Drug Delivery and Translational Research|June 19, 2019
Liposomal OTS964, a TOPK inhibitor: a simple method to estimate OTS964 association with liposomes that relies on enhanced OTS964 fluorescence when bound to albuminRoger Gilabert-Oriol, Brent W Sutherland, Malathi Anantha, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing miceM B Bally, D Masin, R Nayar, et al.
Cancer Research|February 1, 1990
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumorsL D Mayer, M B Bally, H Loughrey, et al.
British Journal of Cancer|March 1, 1995
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumoursL D Mayer, D Masin, R Nayar, et al.
Vaccine|June 14, 2003
Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomesWai Ming Li, Wieslawa H Dragowska, Marcel B Bally, et al.
Anticancer Research|July 9, 2011
Development of glioblastoma cell lines expressing red fluorescence for non-invasive live imaging of intracranial tumorsM Verreault, D Strutt, D Masin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2018
Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitorAda W Y Leung, Malathi Anantha, Wieslawa H Dragowska, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumorsH J Lim, D Masin, N L McIntosh, et al.
Nanomedicine (London, England)|November 15, 2011
Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapyDawn N Waterhouse, Donald Yapp, Maite Verreault, et al.
Pageof 23